A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

NCT06822738 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma

Interventions

DEVICE: XEN63 Glaucoma Treatment System

Sponsor

AbbVie